<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="2.0" xml:lang="EN">
  <front>    <journal-meta>
      <journal-title>Journal of Diabetes and Endocrinology</journal-title>
      <issn pub-type="epub">2141-2685</issn>      <publisher>
        <publisher-name>Academic Journals</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.5897/JDE2014.0077</article-id>
      <title-group>
        <article-title><![CDATA[Minocycline decreases blood glucose and triglyceride levels and reverses histological and immunohisto-chemical alterations in pancreas, liver and kidney of alloxan-induced diabetic rats]]></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
        		        	<name name-style="western">
	            <surname>Glauce</surname>
            <given-names>S. Barros Viana</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Igor</surname>
            <given-names>X. Pessoa</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Pollyana</surname>
            <given-names>L. Tavares Ferreira</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Antnio</surname>
            <given-names>Germano G. Carvalho</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Francisca</surname>
            <given-names>Adilfa O. Garcia</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Silvana</surname>
            <given-names>M. Siqueira Menezes</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Kelly</surname>
            <given-names>Rose Tavares Neves</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Ana</surname>
            <given-names>Paula Negreiros Nunes Alves</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Gilberto</surname>
            <given-names>Santos Cerqueira</given-names>
	          </name>	
        		        	<name name-style="western">
	            <surname>Gerly</surname>
            <given-names>Anne C. Brito</given-names>
	          </name>	
        	        </contrib>
      </contrib-group>
      <author-notes>
		<corresp id="cor1">* E-mail: <email xlink:type="simple">gbviana@live.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
      	<day>31</day>
        <month>05</month>
        <year>2014</year>
      </pub-date>
      <history>
      			<date date-type="received">
			<day>23</day>
			<month>03</month>
			<year>2014</year>
		</date>
						<date date-type="accepted">
			<day>13</day>
			<month>04</month>
			<year>2014</year>
		</date>
			  </history>
      <volume>5</volume>
      <issue>4</issue>
	  	  <fpage>29</fpage>
	  <lpage>40</lpage>
      <permissions>
		<license xlink:type="simple">
			<license-p>
			This is an open-access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
			</license-p>
		</license>
	  </permissions>
	  <self-uri xlink:href="http://politicalwaffle.uk/journal/JDE/article-abstract/A710EFF45002">
		This article is available from http://politicalwaffle.uk/journal/JDE/article-abstract/A710EFF45002	  </self-uri>
	  <self-uri xlink:href="http://politicalwaffle.uk/journal/JDE/article-full-text-pdf/A710EFF45002">
		The full text article is available as a PDF file from http://politicalwaffle.uk/journal/JDE/article-full-text-pdf/A710EFF45002	  </self-uri>
	  
      <abstract><![CDATA[Increasing evidence suggests that oxidative stress and inflammation play major roles in diabetes mellitus and its complications. Furthermore, hyperglycemia increases the production of free radicals, resulting in oxidative stress. Minocycline presents potent anti-inflammatory and antioxidant activities, as evaluated by in vivo and in vitro models. In the present study, the minocycline anti-diabetic effect was assessed in the model of alloxan-induced diabetes. Alloxan was injected to male Wistar rats (50 mg/kg, intravenously), and their blood was collected 48 h later and also after treatments, for measurements of glycemia, triglycerides, cholesterol and liver transaminases. Groups of untreated diabetic controls and diabetic treated with minocycline (1 to 50 mg/kg, peritoneally, p.o.) or glibenclamide (5 mg/kg, p.o., as reference), for different periods, were used. Furthermore, slices of pancreas, liver and kidney were submitted to histological and immunohistochemical analyses. While significant decreases in glucose and triglycerides were shown at the 5th and mainly at the 30th days after minocycline treatments, as compared to the untreated diabetic group, no changes were observed in total cholesterol, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels. Histological analyses of pancreas, liver and kidney showed that minocycline significantly reversed tissue alterations, as those seen in untreated diabetic animals. Besides, minocycline also reduced tumor necrosis factor (TNF)-alpha, cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS) expressions. The beneficial minocycline effects in diabetes could be due, at least partly, to its anti-inflammatory and antioxidant properties, indicating that this drug may be a therapeutic alternative in diabetes mellitus and other pathological conditions where inflammation plays a significant role.

	Key words: Minocycline, diabetes, inflammation, hyperglycemia, hypertriglyceridemia.]]></abstract>
    </article-meta>
  </front>
      <body/>
    <back>
		<ref-list>
			<title>References</title>
						<ref id="ref1">
				<label>1</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Aitken JF, Loomes KM, Scott DW, Reddy S, Phillips AR, Prijic G, Fernando C, Zhang S, Broadhurst R, LHuillier P, Cooper GJ (2010). Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice. Diabetes 59(1):161-171.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref2">
				<label>2</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Alexandraki KI, Piperi C, Ziakas PD, Apostolopoulos NV, Makrilakis K, Syriou V, Diamanti-Kandarakis E, Kaltsas G, Kalofoutis A (2008). Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J. Clin. Immunol. 28(4):314-321.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref3">
				<label>3</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB (1996). A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U. S. A. 93(24):14014-14019.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref4">
				<label>4</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Basu S, Eriksson M (1998). Oxidative injury and survival during endotoxemia. FEBS Lett. 438(3):159-160.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref5">
				<label>5</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L (2000). Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett. 470(1):1-6.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref6">
				<label>6</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M (2004). Clinical potential of minocycline for neurodegenerative disorders. Neurobiol. Dis. 17(3):359-366.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref7">
				<label>7</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM (2000). Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6(7):797-801.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref8">
				<label>8</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Czerny C, Kholmukhamedov A, Theruvath TP, Maldonado EN, Ramshesh VK, Lehnert M, Marzi I, Zhong Z, Lemasters JJ (2012). Minocycline decreases liver injury after hemorrhagic shock and resuscitation in mice. HPB Surg. 2012:259512.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref9">
				<label>9</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MP (2000). Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br. Med. J. 321(7255):199-204.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref10">
				<label>10</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Domercq M, Matute C (2004). Neuroprotection by tetracyclines. Trends Pharmacol. Sci. 25(12):609-612.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref11">
				<label>11</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Drabek T, Janata A, Wilson CD, Stezoski J, Janesko-Feldman K, Tisherman SA, Foley LM, Verrier JD, Kochanek PM (2014). Minocycline attenuates brain tissue levels of TNF- produced by neurons after prolonged hypothermic cardiac arrest in rats. Resuscitation 85(2):284-291.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref12">
				<label>12</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Erbagci AB, Tarakcioglu M, Coskun Y, Sivasli E, Sibel Namiduru E (2001). Mediators of inflammation in children with type 1 diabetes mellitus: cytokines in type 1 diabetic children. Clin. Biochem. 34(8):645-650.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref13">
				<label>13</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D (2002). Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106(16):2067-2072.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref14">
				<label>14</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G (2011). The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr. Diabetes Rev. 7(5):313-324.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref15">
				<label>15</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Forloni G, Colombo L, Girola L, Tagliavini F, Salmona M (2001). Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett. 487(3):404-407.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref16">
				<label>16</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Francs DE, Ingaramo PI, Ronco MT, Carnovale CE (2013). Diabetes, an inflammatory process: oxidative stress and TNF-alpha involved in hepatic complication. J. Biomed. Sci. Eng. 6:645-653.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref17">
				<label>17</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Giacco F, Brownlee M (2010). Oxidative stress and diabetic complications. Cir. Res. 107(9):1058-1070.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref18">
				<label>18</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Giuliani F, Hader W, Yong VW (2005). Minocycline attenuates T cell and microglia activity to impair cytokine production in T-cell-microglia interaction. J. Leukoc. Biol. 78(1):135-143.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref19">
				<label>19</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Goldin A, Beckman JA, Schmidt AM, Creager MA (2006). Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114(6):597-605.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref20">
				<label>20</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998). Tetracyclines inhibit connective tissue breakdown by multiple non antimicrobial mechanisms. Adv. Dent. Res. 12(2):12-26.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref21">
				<label>21</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Golub LM, Ramamurthy NS, Llavaneras A, Ryan ME, Lee HM, Liu Y, Bain S, Sorsa T (1999). A chemically modified non-antimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann. N. Y. Acad. Sci. 878:290-310.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref22">
				<label>22</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Hartge M, Unger T, Kintscher U (2007). The endothelium and vascular inflammation in diabetes. Diabetes Vasc. Dis. Res. 4(2):84-88.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref23">
				<label>23</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Helmersson J, Vessby B, Larsson A, Basu S (2004). Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109(14):1729-1734.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref24">
				<label>24</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kampoli AM, Tousoulis D, Briasoulis A, Latsios G, Papageorgiou N, Stefanadis C (2011). Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus. Curr. Pharm. Des. 17(37):4147-4158.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref25">
				<label>25</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kelly KJ, Sutton TA, Weathered N, Ray N, Caldwell EJ, Plotkin Z, Dagher PC (2004). Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury. Am. J. Physiol. Renal Physiol. 287(4):F760-766.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref26">
				<label>26</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Krady JK, Basu A, Allen CM, Xu Y, LaNone KF, Gardner TW, Levison SW (2005). Minocycline reduces pro-inflammatory cytokine expression, microglia activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54(5):1559-1565.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref27">
				<label>27</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Kraus RL, Pastecny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW (2005). Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J. Neurochem. 94(3):819-827.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref28">
				<label>28</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Lee SM, Yune TY, Kim SJ, Kim YC, Oh YJ, Markelonis GJ, Oh TH (2004). Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J. Neurochem. 91(3):568-578.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref29">
				<label>29</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Leite LM, Carvalho AG, Ferreira PL, Pessoa IX, Gonalves DO, Lopes AA, Ges JG, Alves VC, Leal LK, Brito GA, Viana GS (2011). Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study. Inflammopharmacology 19(2):99-110.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref30">
				<label>30</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Menezes SMS (2012). Evaluation of the effects of minocycline in diabetic rats submitted to experimental periodontal disease. Ph.D. Thesis in Pharmacology, Federal University of Cear, Brazil, June 2012.]]>
				</mixed-citation>
			</ref>
						<ref id="ref31">
				<label>31</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Mogensen CE (1999). Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42(3):263-285.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref32">
				<label>32</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[OBrien T, Nguyen TT, Zimmerman BR (1998). Hyperlipidemia and diabetes mellitus. Mayo Clin. Proc. 73(10):969-976.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref33">
				<label>33</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Odegaard JI, Chawla A (2012). Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb. Perspect. Med. 2(3):a007724.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref34">
				<label>34</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Orekhov AN (2013). Direct anti-atherosclerotic therapy preventing intracellular cholesterol retention. Health 5(7):11-18.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref35">
				<label>35</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Oudot A, Behr-Roussell D, Compagnie S, Caisey S, Le Coz O, Gorny D, Slexandre L, Giuliano F (2009). Endothelial dysfunction in insulin-resistant rats is associated with oxidative stress and COX pathway dysregulation. Physiol. Res. 58(4): 499-509.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref36">
				<label>36</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Pang J, Chan DC, Barret PH, Watts GF (2012). Postprandial dyslipidemia and diabetes: mechanistic and therapeutic aspects. Curr. Opin. Lipidol. 23(4):303-309.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref37">
				<label>37</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Park K, Gross M, Lee D-H, Holvoet P, Himes JH, Shikany JM, Jabobs Jr DR (2009). Oxidative stress and insulin resistance. Diabetes Care 32(7):1302-1307.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref38">
				<label>38</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Pradham AD, Ridker PM (2002). Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur. Heart J. 23(11):831-834.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref39">
				<label>39</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Reusch JEB (2003). Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? J. Clin. Invest. 112(7):986-988.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref40">
				<label>40</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Rohilla A, Shahjad A (2012). Alloxan induced diabetes: mechanisms and effects. Int. J. Res. Pharm. Biomed. Sci. 3(2):819-822.]]>
				</mixed-citation>
			</ref>
						<ref id="ref41">
				<label>41</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Ryan ME, Ashley RA (1998). How do tetracyclines work? Adv. Dent. Res. 12(2):149-151.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref42">
				<label>42</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Ryan ME, Ramamurthy NS, Golub LM (1998). Tetracyclines inhibit protein glycation in experimental diabetes. Adv. Dent. Res. 12(2):152-158.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref43">
				<label>43</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Ryu JK, Franciosi S, Sattayaprasert P, Kim SU, McLarnon JG (2004). Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 48(1):85-90.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref44">
				<label>44</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Schaffer SW, Jong CJ, Mozaffari M (2012). Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vascul. Pharmacol. 57(5-6):139-149.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref45">
				<label>45</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Schwartz J, Holmuhamedov E, Zhang X, Lovelace GL, Smith CD, Lemasters JJ (2013). Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia/reperfusion injury by inhibition of the mitochondrial calcium uniporter. Toxicol. Appl. Pharmacol. 273(1):172-179.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref46">
				<label>46</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Shi Y, Vanhoutte PM (2009). Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes. J. Diabetes 1(3):151-162.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref47">
				<label>47</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Shurtz-Swisrski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L, Kristal B (2001). Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care 24(1):104-110.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref48">
				<label>48</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Soory M, Tilakaratne A (2006). Oxidative stress induced by TNF-alpha and glucose in an osteoblastic model and therapeutic implications of minocycline. Endocr. Abstracts 12:P45.]]>
				</mixed-citation>
			</ref>
						<ref id="ref49">
				<label>49</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Viana GSB, Carvalho AGG, Peixoto AVB, Bezerra CCB (2010). Minocycline reverses behavior and neurochemical changes in the model of global brain ischemia in rats. 16th World Congress of Basic and Clinical Pharmacology, Denmark, 2010.]]>
				</mixed-citation>
			</ref>
						<ref id="ref50">
				<label>50</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL (2009). Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58(7):1634-1640.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref51">
				<label>51</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM (2002). Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417(6884):74-78.
				]]>
				</mixed-citation>
			</ref>
						<ref id="ref52">
				<label>52</label>
				<mixed-citation publication-type="other" xlink:type="simple">
				<![CDATA[Zozulinska D, Werusz-Wysocka B (2006). Type 2 diabetes mellitus as inflammatory disease. Diabetes Res. Clin. Pract. 74(2):S12-S16.
				]]>
				</mixed-citation>
			</ref>
					</ref-list>
	</back>
    </article>